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Background
Stevens-Johnson syndrome (SJS) / Toxic epidermal
necrolysis (TEN) is a rare, severe, and occasionally fatal
skin reaction caused mainly by medications. The
reported mortality associated with TEN varies from
10-70%. SCORTEN, a severity-of-illness score which
estimates the mortality in TEN has been developed and
validated. Malignancy was considered as 1 of the 7
independent prognostic factors of SCORTEN. However,
the studies focused on the associated factors of malig-
nancy in the mortality of SJS/TEN were limited. In this
study, we tried to analyze the true role of malignancy in
the mortality of SJS/TEN.
Method
We retrospectively reviewed the medical charts of the
patients diagnosed of ve SJS, SJS/TEN overlap syndrome,
and TEN in a single tertiary medical center in Taiwan
from 2002 to 2012.
Result
A total of 527 patients of SJS/TEN were included in this
study (mean age 50.58 years). 55 patients were found to
have malignancies (mean age 65.64 years). The most
common malignancy in patients of SJS/TEN was lung
cancer (10), followed by malignant lymphoma (8), urothe-
lial carcinoma (6), and hepatocellular carcinoma (5), etc.
The mortality was high in the patients with underlying
malignancies (29.09%) compared to those without malig-
nancies (9.51%) (OR=4.3127, p value<0.05). The mortality
varied in malignancies of different kinds or of different
organ systems, however, no statistic significance was
identified. The mortality was higher in the patients with
malignancies of stage 4 (34.48%) compared to those of
stage 0 to 3 (23.81%) without statistic significance.
The patients with malignancies who underwent the
chemotherapy (50%) seemed to have higher mortality
compared to those who did not (22.22%) (OR=3.5,
p value=0.057).
Conclusion
The mortality was significantly higher in patients with
underlying malignancies, but varied in different kinds of
malignancies and malignancies of different organ sys-
tems. The role of malignancy in mortality of SJS/TEN is
far more than current all-or-none consideration of
SCORTEN. Chemotherapy, advanced stage, and certain
kinds of malignancies showed a trend of higher mortal-
ity in patients of SJS/TEN with underlying malignancy.
Further efforts must be done to clarify the true role of
malignancy in the mortality of SJS/TEN.
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